Gold Flex Life Sciences, Inc.
Under the leadership of Dr. Sten Rasmussen in Denmark and Dr. Chris Frederickson in America, the Gold Flex team has developed an elegant solution for the safe and targeted treatment of local osteoarthritis. The patented Gold Flex Therapy allows doctors to intervene and stop the progression of osteoarthritis in one or several joints, while reducing or eliminating pain, restoring mobility, and thus improving the patient’s quality of life.
Gold has been used as a highly effective treatment for arthritic joint pain in western medicine for over 100 years. In fact, the FDA lists gold salts as a registered Disease Modifying Anti-Rheumatoid (DMAR). However, the market had previously moved in another direction.
Gold Flex Life Sciences has proven that treating specific joints locally preserves the effectiveness of gold while eliminating previously observed systemic affects. By injecting a one-time low dose of particles of pure elemental gold within a gold salt solution directly into the joint capsule, they found that the risk of remote injury is completely avoided. The tiny amount injected is equivalent to a weekly dose of Auraofin taken orally.
The Gold Flex Treatment demonstrates that the local injections of Microgold into or surrounding an arthritic joint, can eliminate joint pain and restore mobility in a simple office visit. Currently the procedure is being administered in Aalborg, Denmark, while licensing in the United States in is process.
Gold Flex Life Sciences, Inc. currently has license to 2 issued patents and own 4 pending patents in the United States.
Chronic pain caused by arthritis affects millions of people in the United States every year. About one in four adults with arthritis—15 million people—report experiencing severe joint pain related to arthritis. Additionally, nearly half of adults with arthritis have persistent pain.
Dr. Chris Frederickson, PhD
Dr. Robert McLauchlan, MD, JD
Dr. Gorm Danscher,
Dr. Sten Rasmussen,
Dr. Gregers Gregersen,